Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/2005
08/09/2005US6928318 System and method for assessing the performance of a pharmaceutical agent delivery system
08/09/2005US6928315 Apparatus for impedance imaging coupled with another modality
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction
08/09/2005US6926885 In-vivo diagnostic method by means of near infrared radiation
08/09/2005US6926884 GPIb-lipid bond construct and use thereof
08/09/2005US6926883 by reacting a metal in the permetallate form (MO4*form) with carbon monoxide and a reducing agent, soluble in water but not decomposed by water; imaging agent, radionuclide
08/04/2005WO2005071409A1 Remedy for pancreatic cancer
08/04/2005WO2005071116A1 Modulation of hsv infection
08/04/2005WO2005070475A1 Medical devices visible under magnetic resonance imaging
08/04/2005WO2005070473A1 Ultrasound contrast agents for molecular imaging
08/04/2005WO2005070472A2 High frequency ultrasound imaging using contrast agents
08/04/2005WO2005070471A2 Articles comprising magnetic material and bioactive agents
08/04/2005WO2005070470A1 Optical vascular function imaging system and method for detection and diagnosis of cancerous tumors
08/04/2005WO2005070400A1 Methods and compositions for imaging
08/04/2005WO2005070199A1 Mouse model for psoriasis and psoriatic arthritis
08/04/2005WO2005070003A2 Abuse potential reduction in abusable substance dosage form
08/04/2005WO2005069872A2 High throughput pharmaceutical screening using drosophila
08/04/2005WO2005051305A3 Enhanced drug delivery
08/04/2005WO2005027827A3 Host defense factor x (hdfx)
08/04/2005WO2004089283A3 Compositions and methods for treating viral infections
08/04/2005WO2003062198A3 Integrin targeted imaging agents
08/04/2005US20050171434 Chromophore probes for optical imaging
08/04/2005US20050171433 Multi-functional plasmon-resonant contrast agents for optical coherence tomography
08/04/2005US20050171424 Methods for imaging the lymphatic system using dendrimer-based contrast agents
08/04/2005US20050171419 Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations
08/04/2005US20050171342 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
08/04/2005US20050171202 Modulation of signal transduction
08/04/2005US20050171040 Chemically synthesized double stranded molecules; hypercholesterolemia, hyperlipidemia, cardiovascular and cerebrovascular disorders, aortic stenosis, peripheral vascular disease, atherosclerosis
08/04/2005US20050169959 Medical implants and fibrosis-inducing agents
08/04/2005US20050169958 Medical implants and fibrosis-inducing agents
08/04/2005US20050169932 Uses of monoclonal antibody 8h9
08/04/2005US20050169845 Methods for treating urinary incontinence in mammals
08/04/2005US20050169844 Near infrared imaging agent
08/04/2005US20050169840 Determining whether a factor is a modulator of the transmission of immunity from a female mammal to newborn mammals by consumption of milk from the female; BALB/C female mouse, is exposed to the factor, and then immunized to antigen(s); immunity compared between experimental and control newborns
08/04/2005US20050169839 Biomarker for efficacy of appetite suppressant drugs
08/04/2005US20050169837 Coumarines useful as biomarkers
08/04/2005DE4435650B4 Verfahren zum Herstellen eines granulierten Polymerverbundstoffes A method for producing a granulated polymer composite
08/04/2005CA2554239A1 High frequency ultrasound imaging using contrast agents
08/04/2005CA2554203A1 Modulation of hsv infection
08/04/2005CA2554078A1 Optical vascular function imaging system and method for detection and diagnosis of cancerous tumors
08/04/2005CA2553647A1 Articles comprising magnetic material and bioactive agents
08/04/2005CA2553456A1 Primary central nervous system tumor specific behab isoforms
08/04/2005CA2553221A1 Folate conjugates and complexes
08/04/2005CA2552888A1 Medical devices visible under magnetic resonance imaging
08/04/2005CA2552756A1 Mouse model for psoriasis and psoriatic arthritis
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559725A1 Antigen recognizing antibody
08/03/2005EP1559374A1 Cyanine dyes
08/03/2005EP1559317A1 Nonbacterial prostatitis model animal
08/03/2005EP1558922A2 Identifying therapeutic compounds based on their physical-chemical properties
08/03/2005EP1558616A2 Meso-substituted porphyrins
08/03/2005EP1558595A1 Piperazinyl and diazapanyl benzamides and benzthioamides
08/03/2005EP1558293A2 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
08/03/2005EP1558257A1 Dosage form that is safeguarded from abuse
08/03/2005EP1558220A1 Oral compositions for treatment of diseases
08/03/2005EP1210126B1 Viscosity-standardised compositions which facilitate swallowing in dysphagic subjects
08/03/2005EP0707596B1 Polymer-peptide conjugates
08/03/2005CN1649873A Camptothecin-taxoid conjugates as antimitotic and antitumor agents
08/03/2005CN1212862C Use of intravenous contrast agents for projection mammography
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924116 Method for identifying cells
08/02/2005US6923950 hexokinase ligands for diagnosis of cancer
07/2005
07/28/2005WO2005069027A1 Method for the hyperpolarisation of atomic nuclei and device for carrying out said method
07/28/2005WO2005068483A1 Metal complexes having vitamin b12 as a ligand
07/28/2005WO2005068359A2 Method for enriching hyper-polarized atom nuclei and method for carrying out said method
07/28/2005WO2005067990A1 Methods, compositions, and devices for embolizing body lumens
07/28/2005WO2005067982A2 Methods for imaging the lymphatic system using dendrimer-based contrast agents
07/28/2005WO2005067907A1 Reagent for lacrimation examination and method of lacrimation examination
07/28/2005WO2005067710A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds
07/28/2005WO2005067388A2 Perturbed membrane-binding compounds and methods of using the same
07/28/2005WO2005027828A3 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
07/28/2005WO2005019252A8 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins
07/28/2005WO2005013682A3 Animal model for the analysis of tumor metastasis
07/28/2005WO2005009366A3 Restoring vascular function
07/28/2005WO2004107368A3 Ferrofluids stable in neutral media and ferrofluids employing surface-modified particles
07/28/2005WO2004053093A3 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating
07/28/2005WO2003103597A3 Methods of diagnosing & treating diabetes and insulin resistance
07/28/2005US20050166273 Rat model of diabetic nephropathy
07/28/2005US20050164172 Modulation of HSV infection
07/28/2005US20050163746 Heat shock proteins (HSP) activate lymphocytes to produce immunomodulatory cytokines and influence cytokines, chemokines, and surface antigens; drug screening
07/28/2005US20050163717 Abuse potential reduction in abusable substance dosage form
07/28/2005US20050163716 Methods of preparing gaseous precursor-filled microspheres
07/28/2005US20050163715 Dynamic organ function monitoring agents
07/28/2005US20050163714 Capsules of multilayered neutral polymer films associated by hydrogen bonding
07/28/2005US20050163713 Methods and devices for measuring diffusion by magnetic resonance imaging
07/28/2005US20050163712 Method for identifying bronchoconstriction relaxing substances
07/28/2005US20050163711 Intra-dermal delivery of biologically active agents
07/28/2005DE10360847A1 Medical lubricant gel, useful in ear, nose and throat medicine, urology and gynecology, comprising gel former, care component and antimicrobial
07/28/2005CA2553711A1 Reagent for lacrimation examination and method of lacrimation examination
07/28/2005CA2553304A1 Perturbed membrane-binding compounds and methods of using the same
07/28/2005CA2552916A1 Metal complexes having vitamin b12 as a ligand
07/28/2005CA2552913A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds
07/28/2005CA2552649A1 Methods, compositions, and devices for embolizing body lumens
07/28/2005CA2552523A1 Monoclonal antibodies to mucosal addressin cell adhesion molecule(madcam)
07/27/2005EP1557085A1 Mouse model for human psoriasis
07/27/2005EP1556090A1 Polymer compositions for administration to animals
07/27/2005EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
07/27/2005EP1555996A2 Pharmaceutical identification
07/27/2005EP1318992B1 Imidazole derivatives as raf kinase inhibitors
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 354